Gevaert and Colleagues Discover a Distinct Cancer Subtype and a Biomarker for It
In an article published online in EBioMedicine, Olivier Gevaert and his coauthors showed a novel subtype of head and neck squamous cell carcinoma with important implications for treatment. …
Arnold Shir - March 2017 Employee of the Month
Arnold Shir, a research assistant at Stanford Health Policy, says that his work keeps him on his toes… and that he enjoys every second of it. Sometimes, of course, that’s just what people say, but Arnold’s enjoyment of his work is clear to colleagues like Marcella Alsan, who calls him “a ray of sunshine.” Nicole Feldman says, “I have never met a more positive person than Arnold Shir.” Along with colleagues Michelle Zhao and Elena Lucchese, she specifically remarks on Arnold’s “sunny disposition.”…
Celebrating Administrative Professionals
On May 4, Department of Medicine Staff took a break in their busy schedules to celebrate Administrative Professionals Day.
CERC Fellows Tackle Medication Costs with a Little Help from New Zealand
Challenged to discover new approaches to medication use that would substantially lower US health spending and improve health, a three-person team from CERC launched a global search.
Paul Bollyky Receives Harrington Scholar-Innovator Grant
Harrington Discovery Institute has selected Paul Bollyky as one of its 2017 Scholar-Innovators.
Awards and Honors: May 2017
Celebrating the accomplishments of Department of Medicine faculty and staff…
Project Baseline Launches
The Project Baseline Study - a joint effort between Stanford Medicine, Duke University School of Medicine, and Verily Life Sciences, LLC to map the fundamental aspects of human health - recently launched.
Ines Campero - February 2017 Employee of the Month
Ines Campero works in the Healthy Aging Research and Technology Solutions (HARTS) Lab within the Stanford Prevention Research Center, which Ines says, “conducts clinical trials to test the effectiveness of innovative programs that promote healthy behaviors and environments among diverse midlife and older adults.” Ines is the lab’s social science research professional, which she says, quite modestly, means, “I lead, help and guide the team. I make sure our studies run smoothly, on schedule and meet objectives.”…
Breaking Bad at Stanford: Treating a Growing Population of Patients Who Admit to Methamphetamine Abuse
Methamphetamine abuse is known to be bad for many reasons; one of the least known is its association with pulmonary arterial hypertension. Roham Zamanian has followed the geographic spread of the meth epidemic from its US origin in the California Central Valley to current hotbeds in Appalachia and the Ohio Valley.
Stanford-AstraZeneca Collaboration Funds Two New Projects
The Stanford Center for Clinical Research (SCCR), led by Kenneth Mahaffey, MD (professor of cardiovascular medicine), and AstraZeneca are pleased to announce that they have entered into the second year of their collaboration.
Each month, the Department of Medicine honors a staff member who contributes to our mission through their exceptional dedication, initiative, motivation, positive attitude, customer service and passion about their work. Meet the recipients